Analystreport

Albireo Pharma, Inc. (NASDAQ: ALBO) had its price target raised by analysts at Guggenheim to $59.00.

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations